Before the COVID-19 pandemic, it was renown that chronic wounds affected roughly 2% of the world population. Due to the increase of bedridden patients parting from 2020, it is estimated that the number of affected people in the world has risen to around 4%. Moreover, there is a constant need coming directly form the medical community, for new devices that can help the tele-monitoring of chronic syndromes such as cutaneous ulcers. In the last years our research group has committed itself in the development of the WoundViewer, an integrated telemedical device able to automatically analyse chronic wounds though a Memristor Cellular Automata (MCA) designed and trained for this specific scope. This work will present both the design of the MCA and of the device, and the data obtained form the clinical trial preformed with the device on a cohort of 150 patients suffering from three different kinds of chronic wounds at different states.